Cargando…
Lipo-prostaglandin E(1) modifies cognitive impairment in rats with vascular cognitive impairment by promoting angiogenesis via the VEGF/VEGFR pathway
The pathological mechanism of vascular cognitive impairment (VCI) involves ischemic lesions in the hippocampus. Prostaglandin E1 (PGE1) serves roles in the promotion of vascular endothelial growth factor (VEGF) expression, angiogenesis and enhances blood flow to ischemic regions. However, the effect...
Autores principales: | Liu, Bohui, Zhang, Suping, Xiong, Xifeng, Ling, Li, He, Rui, Wang, Muzhen, Deng, Wanqing, Liu, Zhihe, Li, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548021/ https://www.ncbi.nlm.nih.gov/pubmed/28713958 http://dx.doi.org/10.3892/mmr.2017.6984 |
Ejemplares similares
-
Fluoxetine May Enhance VEGF, BDNF and Cognition in Patients with Vascular Cognitive Impairment No Dementia: An Open-Label Randomized Clinical Study
por: Zhang, Lei, et al.
Publicado: (2021) -
Vascular cognitive impairment
por: Suvarna, Alladi
Publicado: (2009) -
Vascular cognitive impairment
por: Yassuda, Mônica Sanches, et al.
Publicado: (2017) -
Vascular Cognitive Impairment
por: Gottesman, Rebecca F., et al.
Publicado: (2010) -
Rapamycin suppresses angiogenesis and lymphangiogenesis in melanoma by downregulating VEGF-A/VEGFR-2 and VEGF-C/VEGFR-3 expression
por: Wang, Min, et al.
Publicado: (2019)